This study involves the use of a tES device. With tES, both tDCS and tRNS are considered to be safe brain stimulation techniques that rarely result in adverse events. There is currently no evidence of serious side-effects. Criteria for discontinuation that may rarely occur are sores at the tCS administration site, headaches that impair global functioning, and worsening psychosis. Mild side-effects that typically resolve upon discontinuation tCS include light itching under the electrode at the beginning of administration, headache, fatigue, and nausea. The participant may choose to discontinue stimulation at any time during the session if experiencing discomfort or side effects. No other risks are anticipated. Nonetheless, in order to minimize risks, study staff will be using standards of administration that have been shown to be safe in numerous other studies and across more than 2000 studies using tES; this includes length of administration, magnitude of the current, size of electrode sponges used, and method of applying stimulation. Any unanticipated problems or adverse events will be reported according to MVAHCS standard operating procedure.